Table 3 Clinical outcomes at 30 days
Overall | Surgical intervention | Catheter intervention | Thrombolytic therapy | Anticoagulation only | |
|---|---|---|---|---|---|
Number | 76 | 16 | 16 | 16 | 28 |
All-cause death | 23 (30.3%) | 1 (6.3%) | 7 (43.8%) | 4 (25.0%) | 11 (39.3%) |
PE-related death | 23 (30.3%) | 1 (6.3%) | 7 (43.8%) | 4 (25.0%) | 11 (39.3%) |
Major bleeding | 41 (54.0%) | 16 (100%)* | 7 (43.8%) | 6 (37.5%) | 12 (42.9%) |
Intracranial bleeding | 3 (3.9%) | 0 (0.0%) | 0 (0.0%) | 1 (6.3%) | 2 (7.1%) |
Respiratory bleeding | 2 (2.6%) | 0 (0.0%) | 1 (6.3%) | 1 (6.3%) | 0 (0.0%) |
Thoracic cavity/abdominal cavity | 2 (2.6%) | 0 (0.0%) | 0 (0.0%) | 1 (6.3%) | 1 (3.6%) |
Procedure site bleeding | 17 (22.4%) | 0 (0.0%) | 6 (37.5%) | 3 (18.8%) | 8 (28.6%) |
Surgery-related bleeding | 17 (22.4%) | 16 (100%) | 0 (0.0%) | 0 (0.0%) | 1 (3.6%) |